Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume $0.32 -0.03 (-8.09%) (As of 01:30 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Enveric Biosciences Short Interest DataEnveric Biosciences (ENVB) has a short interest of 330,200 shares, representing 4.10% of the float (the number of shares available for trading by the public). This marks a 70.91% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 1.80 million shares to cover all short positions.Current Short Interest330,200 sharesPrevious Short Interest193,200 sharesChange Vs. Previous Month+70.91%Dollar Volume Sold Short$164,835.84Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares9,940,000 sharesFloat Size8,050,000 sharesShort Percent of Float4.10%Today's Trading Volume251,235 sharesAverage Trading Volume1,798,106 sharesToday's Volume Vs. Average14% Short Selling Enveric Biosciences? Sign up to receive the latest short interest report for Enveric Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartENVB Short Interest Over TimeENVB Days to Cover Over TimeENVB Percentage of Float Shorted Over Time Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Enveric Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024330,200 shares $164,835.84 +70.9%4.1%0.7 $0.50 10/15/2024193,200 shares $81,723.60 -2.9%2.4%0.1 $0.42 9/30/2024199,000 shares $94,326.00 -2.8%2.3%0.2 $0.47 9/15/2024204,700 shares $102,554.70 -38.3%2.3%0.2 $0.50 8/31/2024332,000 shares $168,456.80 -29.2%3.8%0.3 $0.51 8/15/2024469,100 shares $226,575.30 -80.9%5.3%0.4 $0.48 Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/31/20242,450,000 shares $1.15 million +1,760.3%31.2%1.7 $0.47 7/15/2024131,700 shares $71,381.40 -13.4%1.7%0.2 $0.54 6/30/2024152,100 shares $95,245.02 -43.4%2.0%0.3 $0.63 6/15/2024268,800 shares $198,912.00 -20.5%3.5%0.5 $0.74 5/31/2024338,100 shares $263,718.00 -50.2%4.5%0.2 $0.78 5/15/2024678,900 shares $534,973.20 +736.1%8.9%0.1 $0.79 4/30/202481,200 shares $76,328.00 -15.1%1.1%0 $0.94 4/15/202495,600 shares $88,095.40 -62.5%1.4%0 $0.92 3/31/2024254,900 shares $254,900.00 +69.5%4.2%0.1 $1.00 3/15/2024150,400 shares $162,432.00 +58.2%3.2%0 $1.08 2/29/202495,100 shares $137,895.00 +47.0%4.2%0 $1.45 2/15/202464,700 shares $54,283.30 +181.3%2.5%0.2 $0.84 1/31/202423,000 shares $16,932.60 -58.6%0.9%0.2 $0.74 1/15/202455,600 shares $71,168.00 +334.4%2.3%1.4 $1.28 12/31/202312,800 shares $16,640.00 +6.7%0.6%0.4 $1.30 12/15/202312,000 shares $16,080.00 +263.6%0.6%0.7 $1.34 11/30/20233,300 shares $4,884.00 -54.8%0.2%0.2 $1.48 11/15/20237,300 shares $10,402.50 -62.4%0.4%0.4 $1.43 10/31/202319,400 shares $33,368.00 -19.5%1.0%0.9 $1.72 10/15/202324,100 shares $50,851.00 +121.1%1.3%0.3 $2.11 9/30/202310,900 shares $25,942.00 -55.0%0.6%0.1 $2.38 9/15/202324,200 shares $55,176.00 -45.3%1.2%0.3 $2.28 8/31/202344,200 shares $95,472.00 -42.3%2.3%0.4 $2.16 8/15/202376,600 shares $182,308.00 +86.4%4.0%0.1 $2.38 7/31/202341,100 shares $109,737.00 +95.7%2.2%0 $2.67 7/15/202321,000 shares $60,270.00 -43.1%1.1%0 $2.87 6/30/202336,900 shares $124,353.00 -65.6%2.0%0 $3.37 6/15/2023107,400 shares $414,564.00 -69.1%5.8%0 $3.86 5/31/2023347,300 shares $1.46 million +1,430.0%18.7%0.1 $4.19 5/15/202322,700 shares $34,050.00 -30.2%1.2%0 $1.50 4/30/202332,500 shares $59,520.50 +44.4%1.8%1 $1.83 4/15/202322,500 shares $34,200.00 +39.8%1.2%0.6 $1.52 3/31/202316,100 shares $26,793.62 +64.3%0.9%0.6 $1.66 3/15/20239,800 shares $16,954.00 +71.9%0.6%0.3 $1.73Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 2/28/20235,700 shares $11,913.00 -38.0%0.3%0.1 $2.09 2/15/20239,200 shares $24,932.00 -37.8%0.5%0.2 $2.71 1/31/202314,800 shares $42,476.00 -53.6%0.8%0.3 $2.87 1/15/202331,900 shares $90,277.00 -21.2%1.7%0.7 $2.83 12/30/202240,500 shares $84,240.00 -11.2%2.0%0.7 $2.08 12/15/202245,600 shares $97,584.00 +27.4%2.3%0.9 $2.14 11/30/202235,800 shares $102,746.00 -17.5%1.8%0.5 $2.87 11/15/202243,400 shares $147,560.00 -37.7%2.2%0.4 $3.40 10/31/202269,700 shares $237,677.00 +36.1%4.7%0.3 $3.41 10/15/202251,200 shares $175,104.00 +55.2%3.6%0.1 $3.42 9/30/202233,000 shares $139,260.00 -60.1%2.3%0.1 $4.22 9/15/202282,800 shares $477,756.00 +11.7%5.8%0.2 $5.77 8/31/202274,100 shares $413,478.00 -21.7%5.4%0.2 $5.58 8/15/202294,600 shares $624,360.00 -43.4%6.9%0.2 $6.60 7/31/2022167,000 shares $1.07 million +158.5%16.7%0.6 $6.40 7/15/202264,600 shares $25.71 million +36.6%7.5%0.8 $398.00 6/30/20222,360,000 shares $505,748.00 -23.9%N/A0.9 $0.21 6/15/20223,100,000 shares $651,000.00 -4.6%N/A1.6 $0.21 5/31/20223,250,000 shares $642,525.00 -2.1%N/A1.5 $0.20 5/15/20223,320,000 shares $664,000.00 -2.4%N/A1.1 $0.20 4/30/20223,400,000 shares $918,340.00 +165.6%N/A1 $0.27 4/15/20221,280,000 shares $384,384.00 -19.5%N/A0.4 $0.30 3/31/20221,590,000 shares $524,700.00 -17.6%N/A0.6 $0.33 3/15/20221,930,000 shares $536,540.00 +498.1%N/A0.8 $0.28 2/28/2022322,700 shares $88,581.15 -67.6%N/A0.1 $0.27 2/15/2022996,300 shares $313,834.50 +421.9%N/A0.8 $0.32 1/31/2022190,900 shares $121,469.67 -67.1%N/A0.3 $0.64 1/15/2022580,200 shares $434,453.76 +143.0%N/A0 $0.75 12/31/2021238,800 shares $222,084.00 -41.9%N/A0.3 $0.93 12/15/2021411,300 shares $435,978.00 -50.8%N/A0.3 $1.06 11/30/2021835,400 shares $1.09 million -45.0%4.0%0.4 $1.30 11/15/20211,520,000 shares $2.74 million -22.5%7.3%0.4 $1.80 10/29/20211,960,000 shares $3.45 million +16.0%13.8%0.5 $1.76 10/15/20211,690,000 shares $3.19 million +33.1%10.9%0.5 $1.89 9/30/20211,270,000 shares $2.63 million -44.5%8.2%0.4 $2.07 9/15/20212,290,000 shares $6.07 million +178.1%14.2%0.7 $2.65 8/31/2021823,600 shares $1.64 million -5.0%5.1%0.3 $1.99 8/13/2021866,800 shares $1.49 million -9.4%5.4%0.7 $1.72 7/30/2021956,800 shares $1.83 million +8.2%5.9%0.7 $1.91 7/15/2021884,400 shares $1.82 million +17.3%5.5%0.6 $2.06 6/30/2021754,300 shares $1.80 million +37.8%4.7%0.5 $2.38 6/15/2021547,600 shares $1.21 million -48.3%3.4%0.3 $2.21 5/28/20211,060,000 shares $2.36 million +183.1%6.5%0.4 $2.23 5/14/2021374,400 shares $711,360.00 -30.3%2.3%0.1 $1.90 4/30/2021536,900 shares $1.33 million -41.1%3.4%0.1 $2.48 4/15/2021911,800 shares $2.28 million +17.5%5.7%0.1 $2.50 3/31/2021776,000 shares $2.30 million +34.6%5.6%0.1 $2.97 3/15/2021576,400 shares $2.13 million +233.8%4.1%0.1 $3.70 2/26/2021172,700 shares $628,628.00 -9.4%2.0%0.1 $3.64 2/12/2021190,700 shares $928,709.00 +110.0%2.2%0.1 $4.87Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. 1/29/202190,800 shares $345,948.00 -42.4%10.0%0.1 $3.81 1/15/2021157,700 shares $657,609.00 No Change17.4%0.2 $4.17 ENVB Short Interest - Frequently Asked Questions What is Enveric Biosciences' current short interest? Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 330,200 shares of ENVB short. 4.10% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest. What is a good short interest ratio for Enveric Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENVB shares currently have a short interest ratio of 1.0. Learn More on Enveric Biosciences's short interest ratio. What is a good short interest percentage for Enveric Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.10% of Enveric Biosciences' floating shares are currently sold short. Is Enveric Biosciences' short interest increasing or decreasing? Enveric Biosciences saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 330,200 shares, an increase of 70.9% from the previous total of 193,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enveric Biosciences' float size? Enveric Biosciences currently has issued a total of 9,940,000 shares. Some of Enveric Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enveric Biosciences currently has a public float of 8,050,000 shares. How does Enveric Biosciences' short interest compare to its competitors? 4.10% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Enveric Biosciences: Sensei Biotherapeutics, Inc. (1.18%), Talphera, Inc. (0.60%), Apollomics, Inc. (0.25%), Conduit Pharmaceuticals Inc. (3.72%), Indaptus Therapeutics, Inc. (1.85%), Kiora Pharmaceuticals, Inc. (1.76%), ImmunoPrecise Antibodies Ltd. (3.05%), Mustang Bio, Inc. (1.59%), Imunon, Inc. (3.52%), Onconetix, Inc. (0.62%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Enveric Biosciences stock? Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enveric Biosciences? A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further. How often is Enveric Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Sensei Biotherapeutics Short Interest Talphera Short Interest Apollomics Short Interest Conduit Pharmaceuticals Short Interest Indaptus Therapeutics Short Interest Kiora Pharmaceuticals Short Interest ImmunoPrecise Antibodies Short Interest Mustang Bio Short Interest Imunon Short Interest Onconetix Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENVB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
